Cotinga Pharmaceuticals Inc COT

Primary Symbol: COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

GREY:COTQF - Post by User

Cotinga Pharmaceuticals Inc

Bullboard Posts

Post by Jonnycomelatelyon Mar 26, 2010 8:12pm

566 Views

Post# 16930533

don't fight the tape

BCB has held up pretty well if you bought low enough.
At this point and price I like SMOD in the chip sector better. New high today based on good earning and guidance ..wait for pull back and buy in the same price range.
Jonny

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!